The aim of the study was to analyze the associations of cytokeratin-18 with not only fatty liver markers but also obesity-related metabolic disturbances, including insulin resistance, impaired lipid metabolism and the secretion of hepatokines, adipokines and pro-inflammatory cytokines. The gene discussed is KRT18; the disease is Obesity.